This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Side Effects of autosuggestion: A Synthesis of Findings from 1 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of autosuggestion: A Synthesis of Findings from 1 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to Dataset
Please check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Main Research Findings

Two studies explored the effects of fenfluramine, a medication sometimes used to treat autism. The first study focused on the side effects of fenfluramine in 12 autistic children. This study, a double-blind, placebo-controlled crossover trial, found that in the initial two weeks of active drug use, listlessness, food refusal, and stomach upset were common. A different pattern of side effects emerged in the final 14 weeks of treatment, including irritability, agitation, and crying alongside continued food refusal. Notably, subjects lost 2.1% of body weight during the active drug phase but gained weight back during the subsequent placebo phase.

The second study 1 examined the historical perspective of therapeutic optimism and its pitfalls. It highlighted that excessive optimism in treatment effectiveness could lead to overlooking potential side effects. This study emphasizes the importance of balancing therapeutic optimism with a cautious approach to potential adverse outcomes.

Reasons for Side Effects

The side effects of fenfluramine are likely due to the drug's impact on neurotransmitters in the brain. Fenfluramine inhibits the reuptake of serotonin, leading to increased serotonin levels. Serotonin plays a crucial role in mood, appetite, sleep, and cognitive function, and elevated levels can potentially cause side effects such as listlessness, appetite loss, stomach upset, irritability, agitation, and crying.

Common Side Effects

Listlessness

Listlessness was frequently observed during the initial two weeks of fenfluramine administration.

Food Refusal

Food refusal was a common side effect both during the initial and later stages of fenfluramine treatment.

Stomach Upset

Stomach upset was observed during the first two weeks of fenfluramine treatment.

Irritability

Irritability was a frequent side effect during the final 14 weeks of fenfluramine treatment.

Agitation

Agitation was observed in many patients during the final 14 weeks of fenfluramine treatment.

Crying

Crying was reported as a side effect during the final 14 weeks of fenfluramine treatment.

Side Effect Management

Listlessness, Stomach Upset

Listlessness and stomach upset, often appearing early in treatment, might be managed by reducing the dosage or adjusting the frequency of fenfluramine administration. For severe symptoms, consult a physician for appropriate treatment.

Food Refusal

Food refusal, a side effect that can occur throughout treatment, requires dietary and nutritional management. Seek guidance from a physician or nutritionist to ensure appropriate dietary intake.

Irritability, Agitation, Crying

Irritability, agitation, and crying, common later in treatment, could potentially be managed by reducing the dosage or adjusting the frequency of fenfluramine administration. If symptoms are severe, consult a physician for appropriate treatment.

Comparison Between Studies

Commonalities

Both studies suggest that fenfluramine can cause side effects in autistic children. Additionally, both emphasize the importance of considering the potential for overlooking adverse outcomes due to overly optimistic views of therapeutic effectiveness.

Differences

The first study used a double-blind, placebo-controlled crossover trial to specifically evaluate the side effects of fenfluramine. In contrast, the second study provided a historical analysis of therapeutic optimism and its potential pitfalls.

Real-World Application Considerations

These studies highlight the potential for side effects associated with fenfluramine in autistic children. Therefore, administering fenfluramine to autistic children requires a cautious approach and a thorough understanding of potential side effects. Consulting a physician to determine the appropriate dosage, frequency, and to promptly report any side effects is crucial.

Limitations of Current Research

These studies have limitations, including relatively small sample sizes. Larger-scale studies are needed to further investigate the long-term effects of fenfluramine. The long-term side effects of fenfluramine are not yet fully understood.

Future Research Directions

Future research should focus on evaluating the long-term side effects of fenfluramine. Further studies are also needed to determine the optimal dosage and frequency of administration for autistic children.

Conclusion

These studies suggest that fenfluramine can cause side effects in autistic children. Exercising caution, understanding potential side effects, and consulting with a physician to determine the appropriate dosage, frequency, and to promptly report any side effects are crucial. Future research is needed to evaluate the long-term side effects of fenfluramine and determine the optimal dosage and frequency for autistic children.


Keywords
Benefit Keywords
Risk Keywords
Literature analysis of 1 papers
Positive Content
0
Neutral Content
1
Negative Content
0
Article Type
0
0
0
0
1

Language : German


This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.